• Proactive - Interviews for investors

  • By: Proactive
  • Podcast
Proactive - Interviews for investors By cover art

Proactive - Interviews for investors

By: Proactive
Listen for free

  • Summary

  • Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
    Show more Show less
Episodes
  • Telomir Pharmaceuticals sees breakthrough potential in Anti-Aging Treatment with Telomir 1

    Telomir Pharmaceuticals sees breakthrough potential in Anti-Aging Treatment with Telomir 1
    May 7 2024
    Telomir Pharmaceuticals Co-Founder Frank O’Donnell joined Steve Darling from Proactive to share what the company believe is groundbreaking potential of their new drug designed to extend telomeres, which could reverse aging and age-related diseases. During a recent interview, O'Donnell elaborated on the drug’s potential, supported by extensive research in mice and successful trials in larger animals like a German shepherd. Drawing from his background in ophthalmology at Johns Hopkins, O'Donnell explained that the drug is developed to fight conditions such as macular degeneration by manipulating telomeres—protective caps on chromosomes that degrade over time. This innovative approach has shifted the company's focus from merely prolonging life to actively reversing signs of aging. O'Donnell also touched on the drug’s promising implications for veterinary medicine, particularly its potential benefits for older dogs suffering from osteoarthritis. Upcoming studies on dogs are planned to further prove the drug's effectiveness before moving to human clinical trials slated to begin in January 2025. Emphasizing the drug's transformative capabilities, O'Donnell spoke of its potential global impact by rejuvenating biological clocks and enhancing overall health. Currently, Telomir Pharmaceuticals is not seeking additional funding, opting instead to focus on advancing their research and commencing significant clinical trials. #proactiveinvestors #telomirpharmaceuticalsinc #nasdaq #telo #antiaging #biopharma #FrankODonnell, #AntiAging, #LongevityResearch, #PharmaceuticalInnovation, #Healthcare, #VeterinaryMedicine, #TelomereExtension, #AgeReversal, #Biotechnology, #ClinicalTrials, #MedicalResearch, #DrugDevelopment, #MacularDegeneration, #Ophthalmology, #JohnsHopkins, #AgingResearch, #LifeExtension, #Pharmaceuticals, #MedicalScience #proactiveinvestors #telomirpharmaceuticalsinc #nasdaq #telo #antiaging #biopharma #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    11 mins
  • North Bay Resources Announces Successful Initial Testing of Bishop Gold Mill Equipment

    North Bay Resources Announces Successful Initial Testing of Bishop Gold Mill Equipment
    May 7 2024
    North Bay Resources CEO Jared Lazerson joined Steve Darling from Proactive to announce the successful completion of the initial power-up and testing phase for the equipment at the Bishop Gold Mill. The tested equipment includes a jaw crusher, ball mill, shaker table, flotation tanks, as well as the associated conveyors and ancillary equipment. All components powered up successfully and are confirmed to be in excellent working order. During the conversation, Lazerson noted that the ball mill bushings are set to be replaced soon to ensure continuous operation. Although the mill was permitted for operation starting in 2019, it has remained inactive until now, resulting in very low operational hours for the equipment which remains in nearly new condition. This includes all wiring, plumbing, and associated fixtures in the mill building and the tailings pond. Furthermore, the company is currently in negotiations to secure feedstock for the mill. They have targeted an initial purchase of 10,000 tons of ore, grading one ounce of gold per ton, which would provide approximately three months of feedstock. This acquisition is projected to yield about 8,500 ounces of gold, assuming an 85% recovery rate, which could potentially generate $20 million in gold revenue at current market prices. #proactiveinvestors #northbayresourcesinc #otc #nbri #mining #bishopgoldmill #JaredLazerson, #CopperExploration, #GoldProduction, #MiningIndustry, #BritishColumbia, #CaliforniaGoldMill, #MiningCEO, #ResourceExploration, #EconomicDevelopment, #MineralResources, #MiningOperations, #GoldMillOperations, #ResourceManagement, #InvestmentOpportunity, #CorporateGrowth, #BusinessStrategy, #EnvironmentalPermitting, #IndustrialExpansion, #MarketStrategy #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    6 mins
  • Norsk Titanium Secures Direct Supply Agreement with Boeing, Achieves Strong Growth Milestones

    Norsk Titanium Secures Direct Supply Agreement with Boeing, Achieves Strong Growth Milestones
    May 7 2024
    Norsk Titanium Vice President, Commercial Nick Mayer joined Steve Darling from Proactive to announce a significant agreement with The Boeing Company, marking a milestone in the company's aerospace-grade structural titanium components manufacturing. Mayer revealed that Norsk Titanium has signed a substantial agreement to directly supply parts to Boeing, solidifying a direct supplier relationship between the two entities. This agreement positions Norsk Titanium as a Tier-1 supplier within Boeing's procurement system, allowing for direct deliveries to Boeing later this year. The deal is expected to provide hundreds of structural components to Boeing through 2025. In addition to the Boeing agreement, Norsk Titanium has recently secured a Master Supply Agreement with Airbus Aerostructures, underscoring its expansion strategy. The company's operational and financial update reflects promising growth, with 21 parts in serial production across multiple customers, resulting in annual recurring revenue of approximately US$6 million. Anticipated expansions are forecasted to elevate revenue to US$50 million by the end of 2024, laying the foundation for a longer-term revenue target of US$150 million by 2026. To support its growth initiatives, Norsk Titanium has successfully completed a private placement of $25 million in an oversubscribed process, providing additional capital for expansion and development. With these significant milestones and robust growth projections, Norsk Titanium is poised for continued success and leadership in the aerospace industry. #proactiveinvestors #norsktitanium #otcqx #norsf #boeing #airbus #NorskTitanium, #aerospace, #additivemanufacturing, #Boeing, #Airbus, #industrialmanufacturing, #aerospaceengineering, #supplychain, #aerospaceindustry, #manufacturing, #technology, #engineering, #industrialpartners, #aircraftparts, #commercialaerospace, #defenceindustry, #production, #businessdevelopment, #strategicpartnerships, #revenuegrowth#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    4 mins
Business & Careers Economics Personal Finance Politics & Government
Show more Show less

What listeners say about Proactive - Interviews for investors

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews
No Reviews are Available